Literature DB >> 2905661

Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat.

J F Nash1, H Y Meltzer, G A Gudelsky.   

Abstract

The ability of atypical and typical antipsychotics to antagonize serotonin (5-HT) receptor-mediated temperature and neuroendocrine responses was tested in rats. Clozapine, melperone and setoperone, three atypical neuroleptics, blocked in a dose-dependent manner, the hyperthermic response to the 5-HT agonist, MK-212, whereas chlorpromazine and haloperidol were ineffective. The hypothermic response to the 5-HT1A agonist, 8-OH-DPAT, was unaltered by any of the atypical neuroleptics tested. Similarly, MK-212-induced corticosterone secretion was blocked in a dose-related manner by clozapine, melperone and setoperone but was relatively unaffected by either haloperidol or chlorpromazine. The increase in corticosterone secretion observed following 8-OH-DPAT administration was not attenuated by pretreatment with the atypical or typical antipsychotics tested. These data indicate that atypical neuroleptics are effective 5-HT2 but not 5-HT1A antagonists in vivo. Conversely, the typical neuroleptics, haloperidol and chlorpromazine do not block the 5-HT receptors involved in activation of the hypothalamic-pituitary-adrenal axis or thermoregulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905661     DOI: 10.1016/0014-2999(88)90544-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

Review 1.  Clinical profile of clozapine: adverse reactions and agranulocytosis.

Authors:  J A Lieberman; A Z Safferman
Journal:  Psychiatr Q       Date:  1992

2.  The presynaptic component of the serotonergic system is required for clozapine's efficacy.

Authors:  Prem N Yadav; Atheir I Abbas; Martilias S Farrell; Vincent Setola; Noah Sciaky; Xi-Ping Huang; Wesley K Kroeze; LaTasha K Crawford; David A Piel; Michael J Keiser; John J Irwin; Brian K Shoichet; Evan S Deneris; Jay Gingrich; Sheryl G Beck; Bryan L Roth
Journal:  Neuropsychopharmacology       Date:  2010-11-03       Impact factor: 7.853

3.  Enhanced responsivity of 5-HT(2A) receptors at warm ambient temperatures is responsible for the augmentation of the 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia.

Authors:  Gongliang Zhang; Rui Tao
Journal:  Neurosci Lett       Date:  2010-12-21       Impact factor: 3.046

Review 4.  Clozapine: new research on efficacy and mechanism of action.

Authors:  H Y Meltzer; B Bastani; L Ramirez; S Matsubara
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  Clozapine and olanzapine, but not haloperidol, reverse cold-induced and lipopolysaccharide-induced cutaneous vasoconstriction.

Authors:  William Walter Blessing
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

6.  Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.

Authors:  M A Lee; J F Nash; M Barnes; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine.

Authors:  R S Kahn; L Siever; M Davidson; C Greenwald; C Moore
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine.

Authors:  H Y Meltzer; M Maes; M A Lee
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Clozapine acts as a 5-HT2 antagonist by attenuating DOI-induced inhibition of male rat sexual behaviour.

Authors:  T Klint; K Larsson
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

Review 10.  Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.